HighTower Advisors
CELG

HighTower Advisors’s Celgene Corp CELG Stock Holding History

HighTower Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-200
Closed -$1K – 2492
2018
Q2 		$1K Buy
+200
New +$16.6K ﹤0.01% 2232
2018
Q1 		– Sell
-4,400
Closed -$2K – 2426
2017
Q4 		$2K Buy
4,400
+4,200
+2,100% +$474K ﹤0.01% 2247
2017
Q3 		$2K Buy
+200
New +$27.2K ﹤0.01% 2198
2017
Q1 		– Sell
-300
Closed -$1K – 2228
2016
Q4 		$1K Buy
+300
New +$33.4K ﹤0.01% 1929
2016
Q3 		– Sell
-500
Closed -$2K – 2015
2016
Q2 		$2K Buy
+500
New +$51.7K ﹤0.01% 1752
2014
Q3 		– Sell
-13,800
Closed -$99K – 1728
2014
Q2 		$99K Sell
13,800
-11,200
-45% -$852K ﹤0.01% 1474
2014
Q1 		$25K Sell
25,000
-400
-2% -$31.7K ﹤0.01% 1471
2013
Q4 		$177K Sell
25,400
-200
-0.8% -$15.8K ﹤0.01% 1331
2013
Q3 		$189K Buy
+25,600
New +$1.79M ﹤0.01% 1171

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

HighTower Advisors's CELG Position: Q4 2019 in Review

HighTower Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 177,637 shares — an estimated $17.6M sold.

HighTower Advisors first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $42.1M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • HighTower Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • HighTower Advisors sold 177,637 Celgene Corp shares in Q4 2019, an estimated $17.6M.
  • HighTower Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • HighTower Advisors's Celgene Corp position peaked at $42.1M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on HighTower Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.